Insmed Inc (INSM)

[wjlknew]

Has anyone read the DNA/TRCA Licensing Agreement? It probably offers insight into what what form INSM's agreement may take, including these definitions:

"1.62 “Phase II Clinical Trial” means those tests and studies in humans required by the FDA which generate sufficient data as to safety, dose ranging and efficacy of a Licensed Product to permit commencement of a Phase III Clinical Trial.

1.63 “Phase II/III or Phase III Clinical Trial” means a controlled study in humans that is prospectively designed, using predetermined endpoints, to demonstrate clinically and statistically the efficacy and safety of a Licensed Product for one or more Indications as a pivotal study intended to lead to FDA Approval of such Licensed Product for such Indication(s)."

Also, how many knew that DNA has opt-in rights to any commercial development of a TRCA drug that is not an orphan designation or for diabetes?

Interesting read.

http://contracts.onecle.com/tercica/genentech.lic.2002.04.15.shtml